How are medicines funded?
- A pharmaceutical company will provide a new application to Medsafe for testing and registration.
(Testing and registration usually takes 1 year).
- The Pharmacology Therapeutic Advisory Committee (PTAC) then examines clinical evidence while
incorporating PHARMAC’s Factors for Consideration.
- PHARMAC then receives a recommendation from PTAC and completes its own analysis and applies
three broad assessments: clinical, economic and commercial.
- If the medicine is approved after these assessments then PHARMAC applies rules around funding for
patient access through the public healthcare system.
What is the waiting list?
- After PTAC have analysed and reviewed the medicine application they recommend them to PHARMAC giving them a priority to be publicly funded.
- PHARMAC delays the decision to make these medicines publicly available by putting these prioritised medicines on the waiting list.
- The waiting list leaves the medicine in limbo with suppliers, healthcare professionals and patients unsure of when or if, it will be publicly funded.
What does New Zealand really invest into medicines?
- Since 2007 the medicines budget has consistently been underfunded. Although there have been minor increases to the budget these investments have not kept up with New Zealand’s increasing population and inflation.
How does New Zealand compare?
Make it Your Priority!
It’s time to make our health system a priority in New Zealand. Modern medicines can improve healthcare options and outcomes for our patients while providing significant cost savings for the health system. With an improved and transparent decision-making process and an adequate level of funding, New Zealand can start utilising the benefits of modern medicines that other countries already receive. Will you put NZ patients first?
Share our message and together let’s make it our priority!